Serotonin-binding proteins in the bovine cerebral cortex interaction with serotonin and catecholamines


     Related Videos
3Ds Max Tutorial - 5 - Binding Objects
Oral Serotonin Supplementation and Weight Loss - Robert Posner MD
Oral Serotonin Supplementation and Weight Loss - Robert Posner MD
Oral Serotonin Supplementation and Weight Loss - Robert Posner MD
Prozac Selective Serotonin Reuptake Inhibitor SSRI

     Related Hubpages

    Field: Medicine  DOWNLOAD  BOOKMARK REPORT
    •  Doc. Url:    Embed Code: 

    • PubMed  status
      (0) (0 Votes)
      		Views: (1029)   Date: (13-03-09)   Pages: ()

    • Author:  Jimenez Del Rio M  Pinxteren J  De Potter W  Ebinger G  Vauquelin G.  

    • Abstract:  Serotonin-binding proteins in the bovine cerebral cortex: interaction with serotonin and catecholamines. Jim enez Del Rio M, Pinxteren J, De Potter W, Ebinger G, Vauquelin G. Department of Protein Chemistry, Free University Brussels, St. Genesius-Rode, Belgium. The soluble serotonin-binding proteins (SBP) present in bovine frontal cortex are very similar to those reported in rat brain. Binding of [3H]serotonin to SBP, present in ammonium sulphate-precipitate d proteins from bovine cortex, requires Fe2+ but not Fe3+. In the presence of an optimal concentration of Fe2+ (0.1 mM), bovine SBP behave as a single class of non-cooperative sites for [3H]serotonin binding (Bmax = 120 +/- 12 pmol/mg protein, KD = 0.12 +/- 0.04 microM, n = 3). Binding of [3H]serotonin is decreased by nucleotides and by reagents which modify sulfhydryl groups and reduce disulfide bonds and by metal ion chelators. Serotonin analogs possessing an hydroxyl group on the indole ring and catecholamine analogs possessing an intact catechol moiety are effective competitors (Ki from 0.1 to 0.3 microM). In both cases, the aliphatic amino group does not contribute to the binding, but the affinity is strongly decreased if aromatic hydroxyl groups are methoxylated. Catecholamine-SBP interactions can also be demonstrated directly by binding experiments. Binding of [3H]dopamine is greatly enhanced by Fe2+, Cu2+ and Mn2+, but not by Fe3+. The Fe(2+)-dependent binding component of [3H]dopamine is saturable (Bmax = 279 +/- 64 pmol/mg protein, KD = 0.19 +/- 0.02 microM, n = 3), and possesses the same physicochemical properties as SBP: it elutes immediately after the void volume on a Sephacryl S100 HR (1.6 x 140 cm) gel filtration column (reflecting aggregation) and it migrates with an apparent molecular weight of 57-58 kDa on native polyacrylamide gel electrophoresis. Whereas the serotonin-storing role of SBP in serotonergic neurons has already been well documented, the present data advocate that these proteins may also possess catecholamine-storin g properties. PMID: 1516655 [PubMed - indexed for MEDLINE]

         Related Documents

           Related Groups

             Related Science News

               More on Sciencestage

               Answers

               News
          • When It Comes To Depression, Serotonin Isn't The Whole Story
            The antidepressant Prozac selectively targets the chemical serotonin. When the drug was introduced in the 1980s, it helped solidify the idea in many minds that depression was the result of a chemical imbalance. But the real story is far more complicated.
          • Diet Doc Announces New Approach For Dieters Who Crave Carbohydrates or Chocolate During HCG Diet
            Diet Doc HCG Diet & Weight Loss announce solutions to cravings for carbohydrates or chocolates, which increase serotonin levels, which is responsible for general overall well-being. Diet Doc announces a new approach for those who find it uncomfortable when they stop consuming these types of foods.New York, NY (PRWEB) February 15, 2012 Diet Doc HCG Diet & Weight Loss announce a new diet approach ...
          • What causes depression? It's more than just serotonin
            When Prozac was introduced in the 1980s, it helped solidify the idea in many minds that depression was the result of a chemical imbalance. But the real story is far more complicated.
          • SSRIs may minimize risk of Sudden Unexpected Death in Epilepsy
            A groundbreaking study published in Elsevier's Epilepsy & Behavior provides evidence in mouse model that drugs known as Selective Serotonin Reuptake Inhibitors (SSRIs; one category of antidepressants) may reduce the risk of Sudden Unexpected Death in Epilepsy (SUDEP).
          • Could antidepressants help reduce the risk of sudden unexpected death in epilepsy?
            A groundbreaking study published in Elsevier's Epilepsy & Behavior provides evidence in mouse model that drugs known as Selective Serotonin Reuptake Inhibitors (SSRIs; one category of antidepressants) may reduce the risk of Sudden Unexpected Death in Epilepsy (SUDEP).
          • Antidepressants may delay breast milk production
            Prescription pills are pictured in a file photo. Widely used antidepressants known as selective serotonin reuptake inhibitors (SSRIs) may delay a woman's breast milk production soon after giving birth, a new study hints.
          • Surprising Depression Treatments Show Promise
            Traditional antidepressants like Prozac are widely used to treat depression by boosting serotonin levels, which researchers have long believed are at the root of depression. Research shows that other drugs, including ketamine — also known by its street name, Special K — may be more effective.
          • Nursing home residents with dementia: Antidepressants are associated with increased risk of falling
            Nursing home residents with dementia who use average doses of selective serotonin reuptake inhibitors (SSRIs) are three times more likely to have an injurious fall than similar people who don't use these drugs. The association can be seen in people who use low doses of SSRIs and the risk increases as people take higher doses. The results are published in the British Journal of Clinical ...
          • Rottenstein Law Group Learns of SSRI Antidepressants' Potential to Cause Male Infertility
            The Rottenstein Law Group, which represents clients with claims stemming from the side effects caused by the antidepressant Zoloft, has learned that drugs in the Selective Serotonin Reuptake Inhibitor class of antidepressants can make a man who is taking SSRIs temporarily infertile.New York, NY (PRWEB) February 15, 2012 SSRIs including Zoloft can decrease a man's sperm count by as much as 50 ...
          • Antidepressants Might Raise Fall Risk in Nursing Homes
            WEDNESDAY, Jan. 18 (HealthDay News) -- Antidepressants called selective serotonin reuptake inhibitors (SSRIs) are associated with an increased risk of falls in nursing home residents with dementia, a new study finds.

               Related on Wikipedia




























           

          Powered free by PHPmotion